Media coverage
Podcast / Media Appearance
October 7, 2026
Naltrexone Implants — DeBinge Featured on Avoiding the Addiction Affliction
Waldemar Jezierski, Business Development Manager for DeBinge, joined host Mike McGowan on Avoiding the Addiction Affliction for a discussion focused on naltrexone implants and addiction treatment. The programme explores substance use disorders with expert guests and is distributed across major podcast platforms. The appearance introduces listeners to DeBinge’s work in The Bahamas and the role of long-acting naltrexone within a broader recovery programme.
Listen to Avoiding the Addiction Affliction
External Publication
October 2, 2026
Long-Acting Naltrexone Helps People Stay Off Opioids
Psychreg published an expert article by Dr Fergus Law of DeBinge examining how sustained-release naltrexone can support longer-term opioid recovery. The article reviews evidence on relapse prevention and treatment retention, explains why duration of opioid-receptor blockade may matter, and discusses the role of counselling and continuing care alongside long-acting naltrexone. It also highlights Dr George O’Neill’s work developing long-acting naltrexone technology and notes its clinical use by DeBinge in The Bahamas.
External Publication
September 28, 2026
After a Return to Substance Use: A Family’s First 72-Hour Support Plan
Fixing You Now published an expert contribution by Dr Fergus Law, Consultant Psychiatrist specialising in substance misuse and addiction and affiliated with DeBinge. The article gives families a practical first-72-hour framework after a return to substance use, covering immediate safety, overdose response, reconnecting with treatment, identifying relapse warning signs, restoring structure and building a stronger recovery plan.